Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Neurosci Lett Retrieve available abstracts of 117 articles: HTML format

Single Articles

April 2024
1. ZHANG Y, Wu F
   Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.
   Neurosci Lett. 2024 Apr 5:137765. doi: 10.1016/j.neulet.2024.137765.
   PubMed     Abstract available
   
   
   March 2024
2. CHEN J, Su C, Ma Z, Ou X, et al
   Aerobic exercise suppresses cognitive injury in patients with Alzheimer's disease by regulating long non-coding RNA TUG1.
   Neurosci Lett. 2024;826:137732.
   PubMed     Abstract available
   
   
   
3. FENG Q, Li X, Liu R, Liu G, et al
   Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
   Neurosci Lett. 2024;825:137700.
   PubMed     Abstract available
   
   
   February 2024
4. SHIGEMATSU K, Komori N, Ideno M, Yamagishi H, et al
   "Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".
   Neurosci Lett. 2024;825:137705.
   PubMed     Abstract available
   
   
   
5. HUANG W, Chen Q, Zhou P, Ye S, et al
   Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca(2+)/EGFR-PLCgamma pathway.
   Neurosci Lett. 2024 Feb 12:137684. doi: 10.1016/j.neulet.2024.137684.
   PubMed     Abstract available
   
   
   
6. CAKIR M, Sacmaci H
   The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
   Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
   PubMed     Abstract available
   
   
   
7. KAAR A, Weir MP, Rae MG
   Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca(2+) signaling in two rodent models of Alzheimer's disease.
   Neurosci Lett. 2024;823:137664.
   PubMed     Abstract available
   
   
   January 2024
8. XIE YH, Jiang L, Zhang Y, Deng YH, et al
   Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
   Neurosci Lett. 2024;820:137612.
   PubMed     Abstract available
   
   
   
9. ROBBIE L, Fernandez SG, Montoya L, Sagare A, et al
   Age of onset predicted by Abeta profiling in a novel PSEN1 (I180F) mutation.
   Neurosci Lett. 2024;820:137591.
   PubMed     Abstract available
   
   
   
10. CHEN TJ, Hung HS, Cheng TL, Wang DC, et al
    Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain.
    Neurosci Lett. 2024;818:137533.
    PubMed     Abstract available
    
    
    December 2023
11. ZHANG Y, Shen S, Li X, Wang S, et al
    A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer's disease prediction.
    Neurosci Lett. 2023;821:137609.
    PubMed     Abstract available
    
    
    November 2023
12. LIU L, Liu L, Lu Y, Zhang T, et al
    GDP dissociation inhibitor 1 (GDI1) attenuates beta-amyloid-induced neurotoxicity in Alzheimer's diseases.
    Neurosci Lett. 2023;818:137564.
    PubMed     Abstract available
    
    
    
13. ZARIFKAR AH, Zarifkar A, Safaei S
    Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer's disease.
    Neurosci Lett. 2023 Nov 22:137570. doi: 10.1016/j.neulet.2023.137570.
    PubMed     Abstract available
    
    
    
14. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    PubMed     Abstract available
    
    
    
15. ZHANG J, Guo S, Tao R, Wang F, et al
    Neuroprotective effect of plasmalogens on AlCl(3)-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center.
    Neurosci Lett. 2023;818:137560.
    PubMed     Abstract available
    
    
    October 2023
16. GHOLAMI A
    Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Neurosci Lett. 2023;817:137532.
    PubMed     Abstract available
    
    
    
17. KISHORE N, Goel N
    Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Neurosci Lett. 2023 Oct 17:137530. doi: 10.1016/j.neulet.2023.137530.
    PubMed     Abstract available
    
    
    September 2023
18. KAMRANFAR F, Jaktaji RP, Shirani K, Jamshidi A, et al
    Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model.
    Neurosci Lett. 2023 Sep 19:137491. doi: 10.1016/j.neulet.2023.137491.
    PubMed     Abstract available
    
    
    August 2023
19. KARIMI-ZANDI L, Ghorbandaiepour T, Zahmatkesh M
    The increment of annexin V-positive microvesicles versus annexin V-negative microvesicles in CSF of an animal model of Alzheimer's disease.
    Neurosci Lett. 2023;814:137446.
    PubMed     Abstract available
    
    
    
20. BUDHBHATTI U, Joshi C, Chauhan A, Bhatt D, et al
    Association of NOTCH4 and ACHE gene polymorphism in Alzheimer's disease of Gujarat cohort.
    Neurosci Lett. 2023 Aug 4:137428. doi: 10.1016/j.neulet.2023.137428.
    PubMed     Abstract available
    
    
    July 2023
21. KUO YY, Chen WT, Lin GB, Chen YM, et al
    Thermal cycling-hyperthermia ameliorates Abeta(25-35)-induced cognitive impairment in C57BL/6 mice.
    Neurosci Lett. 2023;810:137337.
    PubMed     Abstract available
    
    
    
22. ABOLHASANI F, Pourshojaei Y, Mohammadi F, Esmaeilpour K, et al
    Exploring the potential of a novel phenoxyethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: Insights from STZ animal model of dementia.
    Neurosci Lett. 2023;810:137332.
    PubMed     Abstract available
    
    
    
23. SHAJI S, Palanisamy R, Swaminathan R
    Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments.
    Neurosci Lett. 2023;810:137329.
    PubMed     Abstract available
    
    
    June 2023
24. NAKANISHI K, Norimatsu K, Tani A, Matsuoka T, et al
    Effects of early exercise intervention and exercise cessation on neuronal loss and neuroinflammation in a senescence-accelerated mouse prone 8.
    Neurosci Lett. 2023;808:137297.
    PubMed     Abstract available
    
    
    
25. CHEN L, Wang L, Zhou GF, Liu Y, et al
    TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study.
    Neurosci Lett. 2023;808:137265.
    PubMed     Abstract available
    
    
    
26. WANG M, Zhao H, Zhang Z, Zhao Z, et al
    Down-regulating insulin-like growth factor-1 receptor reduces amyloid-beta deposition in mice cortex induced by chronic sleep restriction.
    Neurosci Lett. 2023;808:137189.
    PubMed     Abstract available
    
    
    
27. HAMSAFAR Y, Chen Q, Borowsky AD, Beach TG, et al
    Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer's disease.
    Neurosci Lett. 2023 Jun 15:137330. doi: 10.1016/j.neulet.2023.137330.
    PubMed     Abstract available
    
    
    
28. DELVENNE JF, Scally B, Rose Burke M
    Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
    Neurosci Lett. 2023;810:137331.
    PubMed     Abstract available
    
    
    April 2023
29. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    PubMed     Abstract available
    
    
    
30. RODRIGUEZ JJ, Terzieva S, Yeh CY, Gardenal E, et al
    Neuroanatomical and morphometric study of S100beta positive astrocytes in the entorhinal cortex during ageing in the 3xTg-Alzehimer's disease mouse model.
    Neurosci Lett. 2023;802:137167.
    PubMed     Abstract available
    
    
    
31. CAI Y, Fu P, Zhang X
    Association of plasma phosphor-tau181 with Abeta levels may vary by APOE epsilon4 status and sex among non-demented old adults.
    Neurosci Lett. 2023;802:137161.
    PubMed     Abstract available
    
    
    
32. SOMERA B, Frick M, Fadel JR
    Age-related changes in basal forebrain afferent activation in response to food paired stimuli.
    Neurosci Lett. 2023;802:137155.
    PubMed     Abstract available
    
    
    March 2023
33. XIONG L, Wang Z
    BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice.
    Neurosci Lett. 2023;801:137159.
    PubMed     Abstract available
    
    
    
34. WANG P, Wang X, Qiao K, Zhang Y, et al
    Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-beta.
    Neurosci Lett. 2023;799:137118.
    PubMed     Abstract available
    
    
    
35. SINGH L, Singh S
    Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Abeta ((1-42)) and NF-kB expression in experimental model of rats.
    Neurosci Lett. 2023;799:137090.
    PubMed     Abstract available
    
    
    
36. LI H, Zhang D, Wang X, Wang S, et al
    Protective effect of glutamic-oxaloacetic transaminase on hippocampal neurons in Alzheimer's disease using model mice.
    Neurosci Lett. 2023;803:137194.
    PubMed     Abstract available
    
    
    
37. WEI R, He JQ, Chen WH, Tam KY, et al
    Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2023 Mar 6:137166. doi: 10.1016/j.neulet.2023.137166.
    PubMed     Abstract available
    
    
    February 2023
38. ZHANG J, Zhao Y, Zhang Y, Gao Y, et al
    Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus.
    Neurosci Lett. 2023;798:137098.
    PubMed     Abstract available
    
    
    
39. PEREZ-GARCIA G, Bicak M, Haure-Mirande JV, Perez GM, et al
    BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT(P301S) mouse model of tauopathy.
    Neurosci Lett. 2023;797:137080.
    PubMed     Abstract available
    
    
    
40. WANG S, Ke S, Liu S, Wang E, et al
    APOE epsilon4 status and plasma p-tau181 interact to influence cognitive performance among non-demented older adults.
    Neurosci Lett. 2023;796:137052.
    PubMed     Abstract available
    
    
    January 2023
41. KUMAR A, Verma A, Chaurasia RN
    Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects.
    Neurosci Lett. 2023;795:137044.
    PubMed     Abstract available
    
    
    
42. RAMIREZ-HERNANDEZ E, Sanchez-Maldonado C, Patricio-Martinez A, Limon ID, et al
    Amyloid-beta (25-35) induces the morphological alteration of dendritic spines and decreases NR2B and PSD-95 expression in the hippocampus.
    Neurosci Lett. 2023;795:137030.
    PubMed     Abstract available
    
    
    
43. DAS S, Datta S, Ghosal A, Chaudhuri NR, et al
    Screening of BACE1 inhibitors with antiamyloidogenic activity: A study of flavonoids and flavonoid derivatives.
    Neurosci Lett. 2023;792:136965.
    PubMed     Abstract available
    
    
    November 2022
44. XIA S, Zhang Y, Peng B, Hu X, et al
    Detection of mild cognitive impairment in type 2 diabetes mellitus based on machine learning using privileged information.
    Neurosci Lett. 2022;791:136908.
    PubMed     Abstract available
    
    
    
45. FARHANGIAN M, Azarafrouz F, Chavoshinezhad S, Dargahi L, et al
    Intranasal interferon-beta alleviates anxiety and depressive-like behaviors by modulating microglia polarization in an Alzheimer's disease model.
    Neurosci Lett. 2022 Nov 14:136968. doi: 10.1016/j.neulet.2022.136968.
    PubMed     Abstract available
    
    
    
46. FOLORUNSO OO, Harvey TL, Brown SE, Chelini G, et al
    The D-serine biosynthetic enzyme serine racemase is expressed by reactive astrocytes in the amygdala of human and a mouse model of Alzheimer's disease.
    Neurosci Lett. 2022;792:136958.
    PubMed     Abstract available
    
    
    October 2022
47. SHEN Q, Patten KT, Valenzuela A, Lein PJ, et al
    Probing changes in brain esterified oxylipin concentrations during the early stages of pathogenesis in Alzheimer's Disease transgenic rats.
    Neurosci Lett. 2022 Oct 18:136921. doi: 10.1016/j.neulet.2022.136921.
    PubMed     Abstract available
    
    
    
48. RAFIEY M, Nosrati R, Babaei P
    Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats.
    Neurosci Lett. 2022;789:136881.
    PubMed     Abstract available
    
    
    September 2022
49. WANG Y, Lv S, Zhou X, Niu X, et al
    Identification of hsa-miR-365b-5p's role in Alzheimer's disease: A combined analysis of miRNA and mRNA microarrays.
    Neurosci Lett. 2022;790:136892.
    PubMed     Abstract available
    
    
    
50. LANG W, Li X, Wang Y, Duan Y, et al
    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
    Neurosci Lett. 2022 Sep 26:136887. doi: 10.1016/j.neulet.2022.136887.
    PubMed     Abstract available
    
    
    
51. TONDELLI M, Salemme S, Vinceti G, Bedin R, et al
    Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment.
    Neurosci Lett. 2022;787:136811.
    PubMed     Abstract available
    
    
    August 2022
52. LONG Y, Cheng Y, Yang J, Yang T, et al
    Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23.
    Neurosci Lett. 2022;785:136771.
    PubMed     Abstract available
    
    
    July 2022
53. RONG Y, Mi X, Ni C, Liu T, et al
    Protective effect of vitamin C on DNA damage in surgery-induced cognitive dysfunction in APP/PS1 mice.
    Neurosci Lett. 2022;784:136740.
    PubMed     Abstract available
    
    
    
54. LIN J, Niu Z, Xue Y, Gao J, et al
    Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;783:136725.
    PubMed     Abstract available
    
    
    
55. KOCA S, Kiris I, Sahin S, Cinar N, et al
    Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.
    Neurosci Lett. 2022 Jul 13:136799. doi: 10.1016/j.neulet.2022.136799.
    PubMed     Abstract available
    
    
    
56. ZHANG Y, Liu D, Yao X, Wen J, et al
    DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation.
    Neurosci Lett. 2022 Jul 7:136770. doi: 10.1016/j.neulet.2022.136770.
    PubMed     Abstract available
    
    
    June 2022
57. WANG J, Wen C, Li J, Chen J, et al
    Automated quantification of brain connectivity in Alzheimer's disease using ClusterMetric.
    Neurosci Lett. 2022 Jun 10:136724. doi: 10.1016/j.neulet.2022.136724.
    PubMed     Abstract available
    
    
    
58. MA X, Liu L, Meng J
    Retraction notice to "MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett. 661 (2017) 57-62].
    Neurosci Lett. 2022;783:136703.
    PubMed    
    
    
    
59. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model.
    Neurosci Lett. 2022;783:136702.
    PubMed     Abstract available
    
    
    May 2022
60. HU Y, Wen C, Cao G, Wang J, et al
    Brain network connectivity feature extraction using deep Learning for Alzheimer's disease classification.
    Neurosci Lett. 2022 May 2:136673. doi: 10.1016/j.neulet.2022.136673.
    PubMed     Abstract available
    
    
    April 2022
61. WANG Y, Yang Y, Liu Y, Guo A, et al
    Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders.
    Neurosci Lett. 2022;777:136587.
    PubMed     Abstract available
    
    
    February 2022
62. PIJEWSKI RS, Sutter PA, Duszak VA, Singh N, et al
    Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
    Neurosci Lett. 2022;772:136480.
    PubMed     Abstract available
    
    
    
63. LI Y, Han X, Fan H, Sun J, et al
    Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
    Neurosci Lett. 2022 Feb 12:136531. doi: 10.1016/j.neulet.2022.136531.
    PubMed     Abstract available
    
    
    
64. AN Y, Qi Y, Li Y, Li Z, et al
    Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
    Neurosci Lett. 2022 Feb 11:136528. doi: 10.1016/j.neulet.2022.136528.
    PubMed     Abstract available
    
    
    January 2022
65. IMA X, Liu L, Meng J
    Expression of concern: MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2022;769:136229.
    PubMed    
    
    
    
66. CHENFEI Z, Haizhen Y, Jie X, Na Z, et al
    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;767:136303.
    PubMed     Abstract available
    
    
    
67. QIAN C, Zhang M
    RTN3 - ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy.
    Neurosci Lett. 2022;766:136333.
    PubMed     Abstract available
    
    
    December 2021
68. XUE YY, Chen YH, Lin RR, Huang HF, et al
    Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
    Neurosci Lett. 2021 Dec 24:136419. doi: 10.1016/j.neulet.2021.136419.
    PubMed     Abstract available
    
    
    
69. WANG M, Ren Q, Shi Y, Shu H, et al
    The Effect of Alzheimer's Disease Risk Factors on Brain Aging in normal Chineses: Cognitive Aging and Cognitive Reserve.
    Neurosci Lett. 2021 Dec 16:136398. doi: 10.1016/j.neulet.2021.136398.
    PubMed     Abstract available
    
    
    
70. LAI X, Hu J, Liu H, Lan L, et al
    A short peptide from sAPPalpha binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Neurosci Lett. 2021 Dec 13:136397. doi: 10.1016/j.neulet.2021.136397.
    PubMed     Abstract available
    
    
    November 2021
71. GEORGE B, D Gokhale S, Yaswanth PM, Vijayan A, et al
    Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis.
    Neurosci Lett. 2021;766:136357.
    PubMed     Abstract available
    
    
    
72. ZHOU X, Wang Y, Lv S, Li Y, et al
    Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study.
    Neurosci Lett. 2021;766:136337.
    PubMed     Abstract available
    
    
    
73. ZHANG Y, Zhao Y, Zhang J, Gao Y, et al
    Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Abeta1-42-induced microglia cells.
    Neurosci Lett. 2021;764:136206.
    PubMed     Abstract available
    
    
    October 2021
74. ZHU Z, Liu Y, Li X, Zhang L, et al
    GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal.
    Neurosci Lett. 2021 Oct 22:136300. doi: 10.1016/j.neulet.2021.136300.
    PubMed     Abstract available
    
    
    
75. BANG S, Kuen Song J, Shin SW, Hee Lee K, et al
    Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.
    Neurosci Lett. 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
    PubMed     Abstract available
    
    
    September 2021
76. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    PubMed     Abstract available
    
    
    
77. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    PubMed     Abstract available
    
    
    
78. LU X, Zhang Y, Li H, Jin Y, et al
    Nicotine prevents in vivo Abeta toxicity in Caenorhabditis elegans via SKN-1.
    Neurosci Lett. 2021;761:136114.
    PubMed     Abstract available
    
    
    
79. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available
    
    
    
80. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    PubMed     Abstract available
    
    
    August 2021
81. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    PubMed     Abstract available
    
    
    
82. KIM TA, Chen L, Ge S
    The interplay of neurovasculature and adult hippocampal neurogenesis.
    Neurosci Lett. 2021;760:136071.
    PubMed     Abstract available
    
    
    
83. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    PubMed     Abstract available
    
    
    
84. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    PubMed     Abstract available
    
    
    July 2021
85. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    PubMed     Abstract available
    
    
    
86. YUE L, Liu P, Ma N, Xu Y, et al
    Interaction between extracellular ATP5A1 and LPS alleviates LPS-induced neuroinflammation in mice.
    Neurosci Lett. 2021;758:136005.
    PubMed     Abstract available
    
    
    
87. AREZOUMANDAN S, Cai X, Kalkarni P, Davis SA, et al
    Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Neurosci Lett. 2021;758:136010.
    PubMed     Abstract available
    
    
    
88. SUN B, Yao J, Chen AW, Estillore JP, et al
    Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
    Neurosci Lett. 2021;758:136011.
    PubMed     Abstract available
    
    
    
89. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    PubMed     Abstract available
    
    
    June 2021
90. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    PubMed     Abstract available
    
    
    
91. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    PubMed     Abstract available
    
    
    
92. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available
    
    
    May 2021
93. DAINI E, Secco V, Liao W, Zoli M, et al
    A regional and cellular analysis of the early intracellular and extracellular accumulation of Abeta in the brain of 5XFAD mice.
    Neurosci Lett. 2021;754:135869.
    PubMed     Abstract available
    
    
    
94. HE B, Wang L, Xu B, Zhang Y, et al
    Association between CSF Abeta42 and amyloid negativity in patients with different stage mild cognitive impairment.
    Neurosci Lett. 2021;754:135765.
    PubMed     Abstract available
    
    
    
95. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
    Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
    Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
    PubMed     Abstract available
    
    
    
96. ZARETSKY DV, Zaretskaia MV
    Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
    Neurosci Lett. 2021;756:135959.
    PubMed     Abstract available
    
    
    
97. ZHANG H, Ge H, Li K
    Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
    Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
    PubMed     Abstract available
    
    
    
98. SHAMSIPOUR S, Sharifi G, Taghian F
    Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
    Neurosci Lett. 2021;756:135949.
    PubMed     Abstract available
    
    
    April 2021
99. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
    Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
    Neurosci Lett. 2021;755:135914.
    PubMed     Abstract available
    
    
    
100. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
     Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
     Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
     PubMed     Abstract available
     
     
     
101. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
     Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
     Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
     PubMed     Abstract available
     
     
     
102. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
     Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
     Neurosci Lett. 2021;749:135721.
     PubMed     Abstract available
     
     
     February 2021
103. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
     Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
     Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
     PubMed     Abstract available
     
     
     
104. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
     AGING AND ALZHEIMER S DISEASE CONNECTION: NUCLEAR TAU AND LAMIN A.
     Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
     PubMed     Abstract available
     
     
     
105. JOHNSON MD
     Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
     Neurosci Lett. 2021;746:135649.
     PubMed     Abstract available
     
     
     
106. LIM KH, Kim SH, Yang S, Chun S, et al
     Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
     Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
     PubMed     Abstract available
     
     
     
107. XU L, Dong Q, Xu L, Zou W, et al
     The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
     Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
     PubMed     Abstract available
     
     
     January 2021
108. LIANG C, Mu Y, Tian H, Wang D, et al
     MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
     Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
     PubMed     Abstract available
     
     
     
109. ZHANG B, Wu L, Zhu Q, Dong Y, et al
     Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
     Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
     PubMed     Abstract available
     
     
     
110. WANG Y, Sheng H, Zhao J, Guo L, et al
     Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
     Neurosci Lett. 2021;741:135453.
     PubMed     Abstract available
     
     
     
111. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
     Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
     Neurosci Lett. 2021;740:135447.
     PubMed     Abstract available
     
     
     December 2020
112. WANG J, Guo MN, Liu ZZ, Ma SF, et al
     PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
     Neurosci Lett. 2020;744:135598.
     PubMed     Abstract available
     
     
     
113. TIAN Z, Dong Q, Wu T, Guo J, et al
     MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
     Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
     PubMed     Abstract available
     
     
     November 2020
114. SONG X, Chen J, Hou Z, Xie N, et al
     Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
     Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
     PubMed     Abstract available
     
     
     May 2020
115. LIU HJ, Li XY, Chen H, Yu HL, et al
     Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
     Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
     PubMed     Abstract available
     
     
     April 2020
116. ACERO G, Garay C, Venegas D, Ortega E, et al
     Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
     Neurosci Lett. 2020;724:134876.
     PubMed     Abstract available
     
     
     February 2020
117. ZHANG Z, Gao W, Wang X, Zhang D, et al
     Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
     Neurosci Lett. 2020;720:134749.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.